Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2021 | FY2022 | FY2023 | FY2024 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $621M | $698M | $769M | $868M | $474M | $511M | $1.02B | $782M | $584M | $785M |
| Revenue growth | — | 12.4% | 10.2% | 12.9% | -45.4% | 7.8% | 100.4% | -23.6% | -25.3% | 34.3% |
| Gross profit | $379M | $422M | $454M | $521M | $280M | $295M | $643M | $461M | $312M | $457M |
| Gross margin | 61.0% | 60.4% | 59.1% | 60.1% | 59.1% | 57.7% | 62.7% | 58.9% | 53.4% | 58.2% |
| Operating income | $51.4M | $66.3M | $85.0M | $85.2M | -$88.6M | -$107M | $119M | -$24.2M | -$165M | -$70.5M |
| Operating margin | 8.3% | 9.5% | 11.1% | 9.8% | -18.7% | -21.0% | 11.6% | -3.1% | -28.3% | -9.0% |
| Net income | — | $61.5M | $47.1M | $83.6M | $19.3M | $12.5M | $2.12B | -$34.5M | -$191M | -$64.9M |
| Net margin | — | 8.8% | 6.1% | 9.6% | 4.1% | 2.5% | 206.8% | -4.4% | -32.7% | -8.3% |
| EPS (diluted) | $0.87 | $1.45 | $1.09 | $1.90 | $0.43 | $0.28 | $2.54 | -$1.09 | -$5.93 | -$1.98 |
| Fiscal year | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2021 | FY2022 | FY2023 | FY2024 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $137M | $129M | $190M | $174M | $167M | $136M | $141M | -$30.3M | -$13.9M | $95.7M |
| Capital expenditures | $11.2M | $10.9M | $12.3M | $24.5M | $15.3M | $18.1M | $26.5M | $22.3M | $11.7M | $29.9M |
| Free cash flow | $126M | $118M | $177M | $149M | $151M | $118M | $115M | -$52.6M | -$25.7M | $65.8M |
| Share buybacks | $71.7M | $40.5M | — | $39.3M | $26.7M | $16.3M | $883M | $217M | $16.0K | $0.00 |
| Fiscal year | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2021 | FY2022 | FY2023 | FY2024 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $142M | $114M | $269M | $197M | $227M | $203M | $500M | $228M | $282M | $364M |
| Total assets | $1.04B | $1.08B | $1.54B | $1.62B | $1.67B | $1.99B | $2.17B | $1.44B | $1.22B | $1.27B |
| Total liabilities | $285M | $255M | $582M | $557M | $560M | $794M | $764M | $234M | $143M | $175M |
| Long-term debt | $77.5M | $72.5M | — | — | — | — | — | — | — | — |
| Shareholders' equity | $758M | $827M | $953M | $1.07B | $1.12B | $1.20B | $1.41B | $1.21B | $1.08B | $1.09B |
| Retained earnings | $729M | $802M | $851M | $961M | $981M | $994M | $1.42B | $1.19B | $1.00B | $937M |
| Shares (wtd avg diluted) | 43.8M | 42.4M | 43.3M | 44.0M | 44.3M | 44.4M | 36.0M | 31.8M | 32.2M | 32.7M |
Every figure is extracted from SILICON LABORATORIES INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.